幻覚剤：世界市場展望

出版：BCC Research（BCCリサーチ）　出版年月：2023年4月

Psychedelic Drugs: Global Market Outlook
幻覚剤：世界市場展望

レポート目次　　お問合せ・ご注文　　価格・納期について

Report Highlights

The report provides an overview of the global psychedelic drugs market. This report includes sales forecasts and trends in the market for psychedelic drugs through 2027. It discusses leading companies in the market, product segments, supporting technologies, market dynamics, competitive intelligence and regional trends.

Summary:

The global market for psychedelic drugs reached $REDACTED billion in 2021. This market is projected to grow at a compound annual growth rate (CAGR) of REDACTED% and reach $REDACTED billion by the end of 2027. Growing scientific support for the benefits of psychedelic drugs, regulatory advancements supporting the development of psychedelic drugs, and increasing patient and physician acceptance of these drugs are key growth drivers of the market. However, the side effects of these drugs could hinder market growth. This report segments the global market by drug type, application and geographic region. Based on drug type, the market is categorized into ketamine, gamma-hydroxybutyric (GHB) and others. Ketamine currently dominates the market and accounted for $REDACTED billion in sales in 2021. The market for GHB is expected to show a CAGR of REDACTED% and reach $REDACTED billion by the end of 2027.

Based on application, the market is segmented into resistant depression and anxiety, opiate addiction, post-traumatic stress disorder, narcolepsy and others.

By geographic region, the market is segmented into North America, Europe, Asia-Pacific and the Rest of the World (RoW). In 2021 the North American market for psychedelic drugs was valued at $REDACTED billion, representing approximately REDACTED% of the global market. Key growth drivers include the presence of leading global companies, manufacturing infrastructure, favorable political and economic environments, and the rising demand for these drugs for treating addiction and depression. Asia-Pacific is currently the fastest-growing regional market. It was valued at $REDACTED million in 2021 and is projected to grow at a CAGR of REDACTED% and reach $REDACTED billion by the end of 2027.

Report Scope:

This report includes sales forecasts and trends in the market for psychedelic drugs through 2027. It discusses leading companies in the market, product segments, supporting technologies, market dynamics, competitive intelligence and regional trends. It also discusses market the competitive scenarios that will form the base data for qualitative analysis and market estimates.

In this report, the global market for psychedelic drugs is segmented into four geographic regions: North America, Europe, Asia and RoW (South America, the Middle East and Africa).

Report Includes:

– 12 data tables and 9 additional tables
– A brief general outlook of the global market for psychedelic drugs within the biopharmaceutical industry
– Analyses of the global market trends, with historic sales data for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
– Highlights of the current and future market potential of psychedelic drugs, along with detailed analyses of the competitive environment, regulatory scenario, pipeline analysis, technological advancement and market dynamics
– Estimation of the actual market size and revenue forecast for global psychedelic drugs market in USD million values, and corresponding market share analysis based on drug type, application, and region
– Information on stringent regulatory policies and government guidelines to impede the adoption rate of the psychedelic drugs
– Review of key marketed and pipelined products indicated for different therapeutic applications, clinical trials, and penetration of technologies and research initiatives within the ecosystem
– Company profiles of major players within the industry, including Pfizer Inc., Celon Pharma, Cybin Corp., Jazz Pharmaceuticals Inc., and PharmaTher Holdings Ltd.

目次

Table of Contents
Chapter 1 Market Outlook
1.1 Market Snapshot
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4 Market Breakdown by Drug Type
4.1 Market by Drug Type
4.2 Ketamine
4.3 Gamma-hydroxybutyric Acid (GHB)
4.4 Others
Chapter 5 Market Breakdown by Application
5.1 Market, by Application
5.2 Resistant Depression and Anxiety
5.3 Opiate Addiction
5.4 Post-Traumatic Stress Disorder
5.5 Narcolepsy
5.6 Others
Chapter 6 Market Breakdown by Region
6.1 Global Market, by Region
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Rest of the World
Chapter 7 Psychedelic Drugs and Precision Medicine
Chapter 8 Industry Structure
8.1 Company Rankings
8.2 Recent Key Developments
Chapter 9 Company Profiles
CELON PHARMA S.A.
CYBIN CORP.
HIKMA PHARMACEUTICALS PLC.
JAZZ PHARMACEUTICALS INC.
MIND MEDICINE INC.
PFIZER INC.
PHARMATHER HOLDINGS LTD.
REVIVE THERAPEUTICS LTD.
Chapter 10 Project Scope and Methodology
10.1 Scope of Report
10.2 Methodology
10.3 Analyst’s Credentials
10.4 BCC Custom Research
10.5 Related BCC Research Reports

List of Tables
Summary Table : Global Market for Psychedelic Drugs, by Region, Through 2027
Table 1 : Global Market for Psychedelic Drugs, by Drug Type, Through 2027
Table 2 : Global Market for Psychedelic Drugs, by Application, Through 2027
Table 3 : Global Market for Psychedelic Drugs, by Region, Through 2027
Table 4 : North American Market for Psychedelic Drugs, by Drug Type, Through 2027
Table 5 : North American Market for Psychedelic Drugs, by Application, Through 2027
Table 6 : European Market for Psychedelic Drugs, by Drug Type, Through 2027
Table 7 : European Market for Psychedelic Drugs, by Application, Through 2027
Table 8 : Asia-Pacific Market for Psychedelic Drugs, by Drug Type, Through 2027
Table 9 : Asia-Pacific Market for Psychedelic Drugs, by Application, Through 2027
Table 10 : RoW Market for Psychedelic Drugs, by Drug Type, Through 2027
Table 11 : RoW Market for Psychedelic Drugs, by Application, Through 2027
Table 12 : Ranking of Psychedelic Drug Companies, 2021
Table 13 : Recent Key Developments in the Global Market for Psychedelic Drugs
Table 14 : Celon Pharma: Products
Table 15 : Cybin Corp.: Pipeline Products
Table 16 : Hikma Pharmaceuticals: Products
Table 17 : Jazz Pharmaceuticals Inc.: Products
Table 18 : Mind Medicine: Pipeline Products
Table 19 : Pfizer Inc.: Product
Table 20 : PharmaTher Holdings Ltd.: Pipeline Product

List of Figures
Summary Figure A : Global Market Shares of Psychedelic Drugs, by Region, 2021
Summary Figure B : Growth Rates of the North American, European and Asia-Pacific Markets for Psychedelic Drugs, 2022–2027
Figure 1 : Global Market Shares of Psychedelic Drugs, by Drug Type, 2021
Figure 2 : Global Market Shares of Psychedelic Drugs, by Application, 2021
Figure 3 : Global Market for Psychedelic Drugs, by Region
Figure 4 : Global Market Shares of Psychedelic Drugs, by Region, 2021